Lyfspn Working on Clinical Trials of Plasmapheresis

Source https://www.fightaging.org/archives/2022/06/lyfspn-working-on-clinical-trials-of-plasmapheresis/

Parabiosis studies involve connecting the circulatory systems of two genetically identical mice, resulting in modest rejuvenation in the older mouse of the pair. The path from those animal studies to age-modifying therapies in humans has been one of twists and turns. At first, the research community focused on potentially beneficial factors in young blood. Elevian’s work on GDF11 is still ongoing as an outcome of that research. Over the same period of time, plasma transfusions from young to old humans have produced a lack of convincing data.

Source https://www.fightaging.org/archives/2022/06/lyfspn-working-on-clinical-trials-of-plasmapheresis/

Parabiosis studies involve connecting the circulatory systems of two genetically identical mice, resulting in modest rejuvenation in the older mouse of the pair. The path from those animal studies to age-modifying therapies in humans has been one of twists and turns. At first, the research community focused on potentially beneficial factors in young blood. Elevian’s work on GDF11 is still ongoing as an outcome of that research. Over the same period of time, plasma transfusions from young to old humans have produced a lack of convincing data.

What Do You Think?

comments

Translate »